Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials.

Both TODAY and RISE studies have provided critical insight into the unique aspects of the pathophysiology of youth-onset type 2 diabetes and also provided the evidence base for our current approach to the management of this disorder.